Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Alzheimer’s Disease Therapeutics: Alternatives to Amyloid 2021

WEBINAR

Only

Alzheimer’s Disease Therapeutics: Alternatives to Amyloid 2021

Friday, December 3, 2021, 10:00 AM - 5:00 PM EST

Webinar

Presented By

The Brain and Behavior Discussion Group

The New York Academy of Sciences

 

Registration

Member
$85
Nonmember Academia, Faculty, etc.
$105
Nonmember Corporate, Other
$130
Nonmember Not for Profit
$105
Nonmember Student, Undergrad, Grad, Fellow
$40
Member Student, Post-Doc, Fellow
$30
Deadline:
0
days
left

Speakers

Steven E. Arnold, MD

Harvard Medical School, Massachusetts General Hospital

Howard Fillit, MD

Alzheimer's Drug Discovery Foundation

Miranda Orr, PhD

Wake Forest School of Medicine

Robert Paul, MD, PhD

Alector, Inc.

Rudolph Tanzi, PhD

Harvard Medical School, Massachusetts General Hospital

Saul Villeda, PhD

University of California, San Francisco

Christiane Wrann, DVM, PhD

Harvard Medical School, Massachusetts General Hospital

Tony Wyss-Coray, PhD

Stanford University School of Medicine

Scientific Organizing Committee

Howard Fillit, MD
Howard Fillit, MD

Alzheimer's Drug Discovery Foundation

Lisa Mosconi, PhD
Lisa Mosconi, PhD

Weill Cornell Medical College

Rudolph Tanzi, PhD
Rudolph Tanzi, PhD

Harvard Medical School, Massachusetts General Hospital

Sonya Dougal, PhD
Sonya Dougal, PhD

The New York Academy of Sciences

Barbara Knappmeyer, PhD
Barbara Knappmeyer, PhD

The New York Academy of Sciences

Friday

December 03, 2021

Welcome Remarks

Speaker

Barbara Knappmeyer, PhD
The New York Academy of Sciences

Session 1: Neurogenesis and Neuroprotection

10:10 AM

Peripheral Neuroprotective Factors

Speaker

Tony Wyss-Coray, PhD
Stanford University School of Medicine
10:40 AM

Exercise and Neurogenesis

Speaker

Christiane Wrann, DVM, PhD
Massachusetts General Hospital, Harvard Medical School
11:10 AM

Break

Session 2: Brain and Peripheral Organ Interactions

11:25 AM

Liver-to-Brain Axis: Regenerative Effects of Gpld1 on the Aging Brain

Speaker

Saul Villeda, PhD
University of California San Francisco
11:55 AM

Speaker to Be Announced

12:25 PM

Lunch Break

Session 3: Data Blitz Talks and Poster Session

1:10 PM

Virtual Poster Session / Networking

2:10 PM

Blitz Talk 1: Selected from Abstract Submissions

2:25 PM

Blitz Talk 2: Selected for Abstract Submissions

Session 4: Panel Discussion

2:40 PM

Panel Discussion: What's next in AD drug development?

Speakers

Moderator: Rudolph Tanzi, PhD
Harvard Medical School
Howard Fillit, MD
Alzheimer’s Drug Discovery Foundation
Additional Panelists to Be Announced
3:25 PM

Break

Session 5: Clinical Trials

3:40 PM

Amylyx AMX0035 Pegasus Trial

Speaker

Steven E. Arnold
Massachusetts General Hospital, Harvard Medical School
4:10 PM

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease

Speaker

Miranda Orr, PhD
Wake Forest School of Medicine
4:40 PM

AL002 and the INVOKE-2 Trial

Speaker

Robert Paul, MD, PhD
Alector
5:10 PM

Closing Remarks

Speaker

Barbara Knappmeyer, PhD
The New York Academy of Sciences
5:15 PM

Symposium Ends